Delivery of reagents, control materials and consumables for conducting tests, validating and issuing results along with the leasing of analyzers for the Microbiology Department. | Tenderlake

Delivery of reagents, control materials and consumables for conducting tests, validating and issuing results along with the leasing of analyzers for the Microbiology Department.

Contract Value:
PLN 23M - 23M
Notice Type:
Contract Notice
Published Date:
11 June 2025
Closing Date:
11 July 2025
Location(s):
PL213 Miasto Kraków (PL Poland/POLSKA)
Description:
The contract involves delivering reagents, control materials, consumables, and leasing analyzers for various microbiological tests conducted by the Microbiology Department.

The subject of the contract is the delivery of reagents, control materials and consumables for conducting tests, validating and issuing results along with the leasing of analyzers for the Microbiology Department. A detailed description of the subject of the contract is included in Annex No. 1a, 1b to the SWZ. This description should be read together with any changes to the content of the SWZ, resulting from, for example, the responses given to contractors' inquiries. The quantities provided are an estimated demand and are used to calculate the price of the offer (i.e., to determine the maximum remuneration of the contractor). The contracting authority reserves the right to refrain from purchasing part of the assortment due to lack or decrease in demand for a given assortment.


LOT-0001
1
1.
The subject of the contract and the total quantity of tests performed (conducting tests, validating and issuing results): 1. anti-HCV (qualitative) - 240,000 2. anti-HIV/p24 (qualitative) - 120,000 3. HBsAg (qualitative and quantitative) - 120,000 4. anti-HBs (quantitative) - 38,000 5. HBeAg (qualitative and quantitative) - 12,000 6. anti-Hbe (qualitative) - 12,000 7. anti-HBc total (qualitative) - 39,500 8. anti-HBc IgM (qualitative) - 6,500 9. anti-HAV total (qualitative/quantitative) - 6,800 10. anti-HAV IgM (qualitative) - 6,500 11. anti-CMV IgG (quantitative) - 21,000 12. anti-CMV IgM (qualitative) - 21,000 13. avidity anti-CMV IgG - 3,500 14. anti-Rubella IgG (quantitative) - 12,000 15. anti-Rubella IgM (qualitative) - 12,000 16. anti-Toxo IgG (quantitative) - 21,000 17. anti-Toxo IgM (qualitative) - 21,000 18. avidity anti-Tox IgG - 3,500 19. anti-HSV-1 IgG (qualitative/quantitative) - 3,500 20. anti-HSV-2 IgG (qualitative/quantitative) - 3,500 21. HTLV type I/II (qualitative/quantitative) - 3,900 22. Leasing of two analyzers with an installed water treatment station (2 pcs.) and a laboratory centrifuge (1 pc.)


LOT-0002
2
2.
The subject of the contract and the total quantity of tests performed (conducting tests, validating and issuing results): 1. Qualitative and quantitative detection of CMV DNA in plasma by Real-time PCR - 18,800 2. Qualitative and quantitative detection of EBV DNA in plasma by Real-time PCR - 16,850 3. Qualitative and quantitative detection of HIV-1 RNA in plasma by Real-time PCR - 9,000 4. Qualitative and quantitative detection of HBV DNA in plasma by Real-time PCR - 23,000 5. Qualitative and quantitative detection of HCV RNA in plasma by Real-time PCR - 17,000 6. Qualitative detection and differentiation of HIV-1, HIV-2 in plasma by Real-time PCR - 4,500 7. Collection of material and qualitative detection of high-risk HPV DNA (Human Papillomavirus) with simultaneous differentiation of types 16 and 18 and pooled types 12 hrHPV (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) in samples from the cervix and vagina by Real-time PCR - 8,000 8. Leasing of an automated IVD system for the isolation of nucleic acids (RNA, DNA) and Real-time PCR analysis for in vitro medical diagnostics, along with additional assortment necessary for the operation of the device - 1 piece


LOT-0003
3
3.
The subject of the contract and the total quantity of tests performed (conducting tests, validating and issuing results): 1. Detection of carbapenemase genes: OXA-48, KPC, NDM, VIM, IMP - 40,000 2. Leasing of a Real-time PCR analyzer with the ability to test on interchangeable plates (96-well and > 300 wells). Minimum 7 detection channels


LOT-0004
4
4.
The subject of the contract and the total quantity of tests performed (conducting tests, validating and issuing results): 1. Identification and differentiation of Gram-positive infectious agents from positive blood cultures - 2,500 2. Identification and differentiation of Gram-negative infectious agents from positive blood cultures - 2,000 3. Identification and differentiation of fungal infectious agents from positive blood cultures - 50 4. An automated minimum 3-module closed IVD system for the isolation of nucleic acids and multiplex PCR diagnostics in real time along with the necessary additional assortment - 1 piece

The Buyer:
SZPITAL UNIWERSYTECKI W KRAKOWIE
Additional information:
Link:
View Full Notice
Link:
Additional document: DFP.271.95.2025.ADB
Link:
Download Full Notice as PDF
CPV Code(s):
33696500 - Laboratory reagents
38434500 - Biochemical analysers
48000000 - Software package and information systems
71356300 - Technical support services
72260000 - Software-related services
72267000 - Software maintenance and repair services